LRRK2 and Parkinson disease: Specifically, astrocytes derived from iPSCs obtained from PD patients carrying a mutation in the LRRK2 gene exhibit fragmented mitochondrial structures, diminished cell sizes, disrupted Ca2+ signaling, and metabolic dysfunction [192].